CV Sciences, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
CV Sciences, Inc. (CVSI) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $93.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-26
- CV Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $93.00K, a 97.70% decline from fiscal 2024.
- CV Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $4.05M, a 863.57% increase from fiscal 2023.
- CV Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $420.00K, a 76.60% decline from fiscal 2022.
- CV Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $1.79M, a 660.59% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $93.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $4.05M 10-K · filed 2025-03-27 |
| 2023-12-31 | $420.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | $1.79M 10-K · filed 2024-03-29 |
| 2021-12-31 | $236.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $569.00K 10-K · filed 2022-04-04 |
| 2019-12-31 | -$274.00K 10-K · filed 2021-03-19 |
| 2018-12-31 | -$2.68M 10-K · filed 2020-03-30 |
| 2017-12-31 | $685.00K 10-K · filed 2019-03-12 |
| 2016-12-31 | $553.83K 10-K · filed 2018-03-30 |
| 2015-12-31 | $1.69M 10-K · filed 2017-03-31 |
| 2014-12-31 | $2.29M 10-K · filed 2016-04-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-31 |